Editorial
Systemic management for patients with hepatobiliary tumors in a multi-dimensional view
Abstract
As one of the most leading causes of cancer-related mortality, hepatobiliary tumors (HBT) are featured as limited treatment and poor survival. Due to the complexity and heterogeneity of epidemiologic risk factors, clinicopathological characteristics and cancer genomics, it is still hard to form a normalized clinical management for patients with advanced HBT.
